JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Roberton James Stevenson, the Executive Vice President and Chief HR Officer at Addus HomeCare Corp (NASDAQ:ADUS), recently sold 873 shares of the company’s common stock. The transaction, which took place on February 24, 2025, was executed at a price of $108.18 per share, resulting in a total value of approximately $94,441. This sale was conducted under a pre-established 10b5-1 plan, primarily to cover tax obligations related to the vesting of restricted stock awards. The stock, which has declined 13.17% year-to-date and is currently trading at $97.53, shows signs of being oversold according to technical indicators tracked by InvestingPro.
In a separate transaction on February 21, 2025, Stevenson acquired 3,776 shares of Addus HomeCare common stock. These shares were acquired at no cost and are set to vest in equal installments over the next three years, contingent upon continued service and potential acceleration in the event of a change in control. Following these transactions, Stevenson holds a total of 13,120 shares in the company. For deeper insights into insider trading patterns and 12 additional ProTips about ADUS, including detailed valuation metrics, visit InvestingPro.
In other recent news, Addus HomeCare Corporation reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.38 against a forecast of $1.35. Revenue also exceeded projections, reaching $297.1 million compared to the anticipated $284.28 million. Despite these positive financial results, the company’s stock experienced a decline, which may reflect investor concerns about broader market conditions or internal challenges. Addus HomeCare completed a significant acquisition and introduced new technology for caregivers, indicating a strategic focus on growth and innovation. The company faces challenges in the clinical labor market, particularly in hiring nursing staff, and potential changes in Medicaid policy remain a concern. Looking ahead, Addus HomeCare targets a 10% annual revenue growth and expects growth in personal care hours and the hospice segment. The company remains committed to strategic acquisitions, as highlighted by its recent acquisition of Gentiva Personal Care, which added approximately $280 million in annualized revenues. Analysts from firms like Bank of America and RBC Capital Markets have engaged with the company regarding its strategic plans and market challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.